Despite Aveanna Healthcare's recent rally, its P/S ratio remains low amid predictions its growth will lag industry standards. This suggests investor expectation of limited future growth and a reluctance to pay more for its current state, likely averting a substantial price rise soon.
Despite steady returns on capital employed, Aveanna Healthcare Holdings is not displaying potential for high growth. Market optimism should be tempered in light of current underlying trends.
Aveanna Healthcare股票讨论区
Can’t buy this at moomoo?
Loaded
专栏Top upgrades and downgrades on 7/5: SHOP, HPQ, CROX, NTES and more
• $Antero Resources(AR.US)$ : Truist Securities Upgrades to Buy from Hold - PT $50 (from $42)
• $Coinbase(COIN.US)$ : US Tiger Securities Upgrades to Hold from Sell - PT $50
• $卡骆驰(CROX.US)$ : Loop Capital Upgrades to Buy from Hold - PT $75
• $Excelerate Energy(EE.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $29
• $德州仪器(TXN.US)$ : DZ Bank Upgrades to Hold from Buy - PT $150
Downgrades
• $Aveanna Healthcare(AVAH.US)$ : Truist ...
专栏Top upgrades and downgrades on 6/21: XOM, ADBE, UAA, BEKE and more
• $反导工业(ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $美国电塔(AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $丘奇&德怀特(CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy(CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $康西哥(CNC.US)$ : Credit Suisse Upgrades to Outperform from...
暂无评论